Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of Influenza A virus

Journal of Biomolecular Structure and Dynamics

Volumn 33, Issue 9, 2015, Pages 1899-1912

  Tarus, Bogdan ^a,c   Bertrand, Hélène ^b   Zedda, Gloria ^b   Di Primo, Carmelo ^b   Quideau, Stéphane ^b   Slama Schwok, Anny ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INST DE BIOLOGIE PHYSICO CHIMIQUE   (France)

Author keywords

drug design; molecular modelling; nucleoprotein; oligomerization; viral RNA

Indexed keywords

NAPROXEN A; NAPROXEN C0; NAPROXEN DERIVATIVE; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN; VIRUS RNA; ANTIVIRUS AGENT; NAPROXEN; NUCLEOPROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DENATURATION; DRUG BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; INFLUENZA VIRUS A; MOLECULAR DYNAMICS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN TARGETING; RNA BINDING; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG EFFECTS; HUMAN; INFLUENZA A VIRUS; INFLUENZA, HUMAN; PROTEIN MULTIMERIZATION; VIROLOGY;

INFLUENZA A VIRUS;

ANTIVIRAL AGENTS; BINDING SITES; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MOLECULAR DYNAMICS SIMULATION; NAPROXEN; NUCLEOPROTEINS; PROTEIN MULTIMERIZATION; RNA, VIRAL;

EID: 84937252826     PISSN: 07391102     EISSN: 15380254     Source Type: Journal    
DOI: 10.1080/07391102.2014.979230     Document Type: Article

References (42)

1. Arranz, R., Coloma, R., Chichon, F. J., Conesa, J. J., Carrascosa, J. L., Valpuesta, J. M., ... Martin-Benito, J. (2012). The structure of native influenza virion ribonucleoproteins. Science, 338, 1634-1637.
2. Butler, J., Hooper, K. A., Petrie, S., Lee, R., & Maurer-Stroh, S. (2014). Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses. PLoS Pathogens, 10, e1004065.
3. Chan, W. H., Ng, A. K., Robb, N. C., Lam, M. K., Chan, P. K., Au, S. W., ... Shaw, P. C. (2010). Functional analysis of the influenza virus H5N1 nucleoprotein tail loop reveals amino acids that are crucial for oligomerization and ribonucleoprotein activities. Journal of Virology, 84, 7337-7345.
4. Chaurasiya, K. R., McCauley, M. J., Wang, W., Qualley, D. F., Wu, T., Kitamura, S., ... Williams, M. C. (2014). Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein. Nature Chemistry, 6, 28-33.
5. Chenavas, S., Crépin, T., Delmas, B., Ruigrok, R. W., & Slama-Schwok, A. (2013). Influenza virus nucleoprotein: Structure, RNA binding, oligomerization and antiviral drug target. Future Microbiology, 8, 1537-1545.
6. Chenavas, S., Estrozi, L. F., Slama-Schwok, A., Delmas, B., Di Primo, C., Baudin, F., ... Ruigrok, R. W. (2013). Monomeric nucleoprotein of influenza A virus. PLoS Pathogens, 9, e1003275.
7. Courchay, F. C., Sworen, J. C., Ghiviriga, I., Abboud, K. A., & Wagener, K. B. (2006). Understanding structural isomerization during ruthenium-catalyzed olefin metathesis: A deuterium labeling study. Organometallics, 25, 6074-6086.
8. Darden, T., York, D. M., & Pedersen, L. (1993). Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98, 10089-10092.
9. Das, K., Aramini, J. M., Ma, L. C., Krug, R. M., & Arnold, E. (2010). Structures of influenza A proteins and insights into antiviral drug targets. Nature Structural & Molecular Biology, 17, 530-538.
10. Elton, D., Medcalf, E., Bishop, K., & Digard, P. (1999). Oligomerization of the influenza virus nucleoprotein: Identification of positive and negative sequence elements. Virology, 260, 190-200.
11. Harvey, R. G., Dai, Q., Ran, C., & Penning, T. M. (2004). Synthesis of the o-Quinones and other oxidized metabolites of polycyclic aromatic hydrocarbons implicated in carcinogenesis. The Journal of Organic Chemistry, 69, 2024-2032.
12. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79, 926-935.
13. Krug, R. M., & Aramini, J. M. (2009). Emerging antiviral targets for influenza A virus. Trends in Pharmacological Sciences, 30, 269-277.
14. Lejal, N., Tarus, B., Bouguyon, E., Chenavas, S., Bertho, N., Delmas, B., ... Slama-Schwok, A. (2013). Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrobial Agents and Chemotherapy, 57, 2231-2242.
15. Longhi, S., Receveur-Brechot, V., Karlin, D., Johansson, K., Darbon, H., Bhella, D., ... Canard, B. (2003). The C-terminal domain of the measles virus nucleoprotein is intrinsically disordered and folds upon binding to the C-terminal moiety of the phosphoprotein. Journal of Biological Chemistry, 278, 18638-18648.
16. Lopez-Martinez, R., Ramirez-Salinas, G. L., Correa-Basurto, J., & Barron, B. L. (2013). Inhibition of influenza A virus infection in vitro by peptides designed in silico. PLoS ONE, 8, e76876.
17. MacKerell, A. D., Jr, Banavali, N., & Foloppe, N. (2000). Development and current status of the CHARMM force field for nucleic acids. Biopolymers, 56, 257-265.
18. Matsunaga, N., Kaku, T., Ojida, A., Tanaka, T., Hara, T., Yamaoka, M., ... Tasaka, A. (2004). C(17,20)-lyase inhibitors. Part 2: Design, synthesis and structure-activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C (17,20)-lyase inhibitors. Bioorganic & Medicinal Chemistry, 12, 4313-4336.
19. Mavrakis, M., Méhouas, S., Réal, E., Iseni, F., Blondel, D., Tordo, N., & Ruigrok, R. W. (2006). Rabies virus chaperone: Identification of the phosphoprotein peptide that keeps nucleoprotein soluble and free from non-specific RNA. Virology, 349, 422-429.
20. Mena, I., Jambrina, E., Albo, C., Perales, B., Ortin, J., Arrese, M., ... Portela, A. (1999). Mutational analysis of influenza A virus nucleoprotein: Identification of mutations that affect RNA replication. Journal of Virology, 73, 1186-1194.
21. Moeller, A., Kirchdoerfer, R. N., Potter, C. S., Carragher, B., & Wilson, I. A. (2012). Organization of the influenza virus replication machinery. Science, 338, 1631-1634.
22. Ng, A. K., Wang, J. H., & Shaw, P. C. (2009). Structure and sequence analysis of influenza A virus nucleoprotein. Science in China Series C: Life Sciences, 52, 439-449.
23. Ng, A. K., Zhang, H., Tan, K., Li, Z., Liu, J. H., Chan, P. K., ... Shaw, P. C. (2008). Structure of the influenza virus A H5N1 nucleoprotein: Implications for RNA binding, oligomerization, and vaccine design. The FASEB Journal, 22, 3638-3647.
24. Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., ... Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26, 1781-1802.
25. Purohit, R. (2014). Role of ELA region in auto-activation of mutant KIT receptor: A molecular dynamics simulation insight. Journal of Biomolecular Structure & Dynamics, 32, 1033-1046.
26. Purohit, R., Rajendran, V., & Sethumadhavan, R. (2011a). Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and isoniazid susceptibility: An in silico analysis. Journal of Molecular Modeling, 17, 869-877.
27. Purohit, R., Rajendran, V., & Sethumadhavan, R. (2011b). Studies on adaptability of binding residues and flap region of TMC-114 resistance HIV-1 protease mutants. Journal of Biomolecular Structure & Dynamics, 29, 137-152.
28. Rajendran, V., Purohit, R., & Sethumadhavan, R. (2012). In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein. Amino Acids, 43, 603-615.
29. Rajendran, V., & Sethumadhavan, R. (2014). Drug resistance mechanism of PncA in Mycobacterium tuberculosis. Journal of Biomolecular Structure & Dynamics, 32, 209-221.
30. Reguera, J., Malet, H., Weber, F., & Cusack, S. (2013). Structural basis for encapsidation of genomic RNA by La crosse orthobunyavirus nucleoprotein. Proceedings of the National Academy of Sciences, 110, 7246-7251.
31. Ruigrok, R. W., Crépin, T., & Kolakofsky, D. (2011). Nucleoproteins and nucleocapsids of negative-strand RNA viruses. Current Opinion in Microbiology, 14, 504-510.
32. Sharma, M., & Ray, S. M. (2008). Synthesis and biological evaluation of amide derivatives of (5,6-dimethoxy-2,3-dihydro-1H-inden-1-yl) acetic acid as anti-inflammatory agents with reduced gastrointestinal ulcerogenecity. European Journal of Medicinal Chemistry, 43, 2092-2102.
33. Shen, Y. F., Chen, Y. H., Chu, S. Y., Lin, M. I., Hsu, H. T., Wu, P. Y., ... Tsai, M. D. (2011). E339 ... R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors. Proceedings of the National Academy of Sciences, 108, 16515-16520.
34. Shih, S. R., Horng, J. T., Poon, L. L., Chen, T. C., Yeh, J. Y., Hsieh, H. P., ... Hsu, J. T. (2010). BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses. Journal of Antimicrobial Chemotherapy, 65, 63-71.
35. Slama Schwok, A., Delmas, B., Quideau, S., Bertrand, H., & Tarus, B. (2012). Antiviral compositions directed against the influenza virus nucleoprotein. International patent extension no PCT/EP2012/001720 deposited April 21, 2012.
36. Sulyok, G. A., Gibson, C., Goodman, S. L., Hölzemann, G., Wiesner, M., & Kessler, H. (2001). Solid-phase synthesis of a nonpeptide RGD mimetic library: New selective alphavbeta3 integrin antagonists. Journal of Medicinal Chemistry, 44, 1938-1950.
37. Tarus, B., Bakowiez, O., Chenavas, S., Duchemin, L., Estrozi, L. F., Bourdieu, C., ... Slama-Schwok, A. (2012). Oligomerization paths of the nucleoprotein of influenza A virus. Biochimie, 94, 776-785.
38. Tarus, B., Chevalier, C., Richard, C. A., Delmas, B., Di Primo, C., & Slama-Schwok, A. (2012). Molecular dynamics studies of the nucleoprotein of influenza A virus: Role of the protein flexibility in RNA binding. PLoS ONE, 7, e30038.
39. Tawar, R. G., Duquerroy, S., Vonrhein, C., Varela, P. F., Damier-Piolle, L., Castagne, N., ... Rey, F. A. (2009). Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science, 326, 1279-1283.
40. Wang, J., Ma, C., Fiorin, G., Carnevale, V., Wang, T., Hu, F., ... DeGrado, W. F. (2011). Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2. Journal of the American Chemical Society, 133, 12834-12841.
41. Ye, Q., Guu, T. S., Mata, D. A., Kuo, R. L., Smith, B., Krug, R. M., & Tao, Y. J. (2012). Biochemical and structural evidence in support of a coherent model for the formation of the double-helical influenza A virus ribonucleoprotein. MBio, 4, e00467-00412.
42. Ye, Q., Krug, R. M., & Tao, Y. J. (2006). The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature, 444, 1078-1082.